Recent Finacing
Recent Raise
ROME Therapeutics operates a repeatomics data-science platform to identify druggable targets within repetitive genomic elements and develop therapeutics—including a LINE-1 reverse transcriptase inhibitor—across autoimmune disease, cancer, and neurodegeneration.
